Interleukin 13, Plasma
Also known as: IL13 PLA
Use
The test is primarily used for research and supports efforts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders. Results are used to gain insights into the pathophysiology of these conditions or may be leveraged for research purposes.
Special Instructions
Not provided.
Limitations
The test was developed and its performance characteristics were determined by ARUP Laboratories. It is not cleared or approved by the US FDA, but is performed in a CLIA certified laboratory and intended for clinical purposes. Refrigerated specimens, contaminated, or heat-inactivated specimens are unacceptable for testing, as they can lead to inaccurate results.
New York Approved
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Interleukin 13
Protein
LOINC Codes
- 33822-8 - Il13 SerPl-mCnc
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate plasma from cells ASAP or within 2 hours of collection. Transfer plasma to an ARUP Standard Transport Tube.
Storage Instructions
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered. Ship in ARUP Standard Transport Tube.
Causes for Rejection
Refrigerated specimens. Contaminated or heat-inactivated specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 minutes |
| Refrigerated | Unacceptable |
| Frozen | 1 year |
Other tests from different labs that may be relevant